Farther Finance Advisors, LLC

Position in MRK — Merck & Co., Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in MRK

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$15,508,022

+$845,634 QoQ

Shares Held

120,685

-1.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#147

of 1,644 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. MRK ranks #4 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc. This page	120,685	$15,508,022
5	AMGN	Amgen Inc	34,711	$12,569,547
6	PFE	Pfizer Inc	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc.	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,508,022	120,685	-1.0%	Shares	Sole	2026-07-17
2026-03-31	$14,662,388	121,892	+24.6%	Shares	Sole	2026-04-07
2025-12-31	$10,296,322	97,818	+48.9%	Shares	Sole	2026-01-23
2025-09-30	$5,514,536	65,704	-21.5%	Shares	Sole	2025-10-14
2025-06-30	$6,623,079	83,667	+108.3%	Shares	Sole	2025-07-11
2025-03-31	$3,604,761	40,160	+60.8%	Shares	Sole	2025-04-14
2024-12-31	$2,484,513	24,975	+2.8%	Shares	Sole	2025-02-10
2024-09-30	$2,758,031	24,287	-2.1%	Shares	Sole	2024-10-29
2024-06-30	$3,071,106	24,807	+49.8%	Shares	Sole	2024-07-31
2024-03-31	$2,185,223	16,561	+14.2%	Shares	Sole	2024-05-14
2023-12-31	$1,581,553	14,507	+54.4%	Shares	Sole	2024-02-15
2023-09-30	$967,421	9,397	+76.5%	Shares	Sole	2023-11-14
2023-06-30	$614,451	5,325	+10.5%	Shares	Sole	2024-05-14
2023-03-31	$512,799	4,820	+61.0%	Shares	Sole	2024-05-14
2022-12-31	$332,073	2,993	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.